Le Cossec C, Perrine A-L, Beltzer N, Fuhrman C, Carcaillon-Bentata L
Laure Carcaillon-Bentata, Santé publique France, Agence nationale de santé publique, TSA 50459, 94415 Saint-Maurice Cedex France, Tel : +33 1 55 12 54 35,
J Nutr Health Aging. 2016;20(8):860-869. doi: 10.1007/s12603-016-0802-2.
To estimate the prevalence of pre-frailty, frailty and multimorbidity in individuals without disability in France. To describe independent determinants of each indicators.
Two nationally representative cross-sectional French surveys.
Wave 2012 of the Health, Health Care and Insurance Survey (Enquête Santé et Protection Sociale, ESPS) and data from the Disability Healthcare Household section Survey (Enquête Handicap Santé - Ménages, HSM) from 2008.
Two representative samples of the French population aged 55 and older (n=4,328 and n=12,295).
Frailty was assessed using Fried's frailty phenotype and multimorbidity was defined as having had at least two groups of the following groups of comorbidities in the last 12 months (cardio or cerebrovascular disease, diabetes, chronic respiratory disease, arthralgia, depression). Independent determinants were studied using weighted logistic regressions.
In the French population over 55 and free of disability, 55 to 62% of individuals were either frail, pre-frail or multimorbid, 22 to 25% being frail or multimorbid. ESPS and HSM prevalences for frailty (11.1% [9.3%-12.1%] and 12.3% [11.5%-13.0%]) and multimorbidity (14.9% [13.6%-16.2%] and 16.8% [15.9%-17.7%]) were consistent across studies. Both frailty and multimorbidity prevalences were associated with age. On the other hand, pre-frailty prevalence varied consistently between studies (from 38 to 48%) and was not significantly associated with age. We found that more than 60% of frail subjects did not present with multimorbidity and around 70% of subjects with multimorbidity were not frail. Determinants of pre-frailty and multimorbidity but not frailty depended on sex. Similar factors were associated with frailty and multimorbidity in women (older age, functional decline, poor mental health, financial difficulties) while only poor mental health was independently associated with both indicators in men.
Our study highlights that in France, among individuals older than 55 years-old and free of disability, around 25% are either frail or multimorbid; another 30% to 40% being pre-frail. Pre-frailty, frailty and multimorbidity are known to be associated with adverse health outcomes and important economic costs. The health system must adapt to respond to the needs of its aging population. In addition, given the efficient impact of prevention actions, our findings emphasize the need to implement prevention strategies against Frailty and multimorbidity in France.
评估法国无残疾个体中衰弱前期、衰弱和多种疾病并存的患病率。描述各指标的独立决定因素。
两项具有全国代表性的法国横断面调查。
2012年健康、医疗保健与保险调查(健康与社会保障调查,ESPS)第20波以及2008年残疾医疗家庭部分调查(残疾健康家庭调查,HSM)的数据。
法国55岁及以上人群的两个代表性样本(n = 4328和n = 12295)。
使用弗里德衰弱表型评估衰弱,多种疾病并存定义为在过去12个月内患有以下至少两组共病(心血管或脑血管疾病、糖尿病、慢性呼吸道疾病、关节痛、抑郁症)。使用加权逻辑回归研究独立决定因素。
在法国55岁及以上且无残疾的人群中,55%至62%的个体为衰弱、衰弱前期或患有多种疾病,22%至25%为衰弱或患有多种疾病。ESPS和HSM中衰弱(分别为11.1% [9.3%-12.1%]和12.3% [11.5%-13.0%])和多种疾病并存(分别为14.9% [13.6%-16.2%]和16.8% [15.9%-17.7%])的患病率在各项研究中一致。衰弱和多种疾病并存的患病率均与年龄相关。另一方面,衰弱前期患病率在各项研究中差异一致(从38%至48%),且与年龄无显著关联。我们发现,超过60%的衰弱个体未患有多种疾病,约70%患有多种疾病的个体不衰弱。衰弱前期和多种疾病并存而非衰弱的决定因素取决于性别。女性中与衰弱和多种疾病并存相关的因素相似(年龄较大、功能下降、心理健康不佳、经济困难),而男性中只有心理健康不佳与这两个指标独立相关。
我们的研究强调,在法国,55岁及以上且无残疾的个体中,约25%为衰弱或患有多种疾病;另外30%至40%为衰弱前期。已知衰弱前期、衰弱和多种疾病并存与不良健康结局及重大经济成本相关。卫生系统必须做出调整以满足其老龄化人口的需求。此外,鉴于预防行动的有效影响,我们的研究结果强调了在法国实施针对衰弱和多种疾病并存的预防策略的必要性。